Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Solesence (SLSN) EBT: 2010-2024

Historic EBT for Solesence (SLSN) over the last 14 years, with Dec 2024 value amounting to $4.5 million.

  • Solesence's EBT fell 136.78% to -$1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 36.90%. This contributed to the annual value of $4.5 million for FY2024, which is 201.78% up from last year.
  • According to the latest figures from FY2024, Solesence's EBT is $4.5 million, which was up 201.78% from -$4.4 million recorded in FY2023.
  • Solesence's 5-year EBT high stood at $4.5 million for FY2024, and its period low was -$4.4 million during FY2023.
  • Over the past 3 years, Solesence's median EBT value was -$2.6 million (recorded in 2022), while the average stood at -$854,000.
  • As far as peak fluctuations go, Solesence's EBT tumbled by 212.01% in 2022, and later skyrocketed by 201.78% in 2024.
  • Over the past 5 years, Solesence's EBT (Yearly) stood at $989,000 in 2020, then soared by 138.32% to $2.4 million in 2021, then crashed by 212.01% to -$2.6 million in 2022, then slumped by 66.06% to -$4.4 million in 2023, then spiked by 201.78% to $4.5 million in 2024.